companies making glp-1 drugs New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our 🚨 FDA Cracks Down on

The lyophilization process removes moisture while helping preserve peptide integrity during storage, allowing researchers to reconstitute the product according to their established laboratory protocols

Presented for research literature review only Zou P et al

Angiogenesis is a crucial process for healing and recovery in many tissues

"This can be from inflammatory conditions like acne or eczema, injury to the skin, hormonal conditions, medications, and sunlight." This is because acne, sunlight, and skin rashes have the potential to stimulate melanocytes the pigment-making cells in the skin to make a surplus of pigment

The range includes phosphatidylcholine, phospholipid complex oils, butyrate and mineral formulations, with particular focus on membrane and mitochondrial health

Front Oncol 8:617 Venneti S, Dunphy MP, Zhang H et al (2015) Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo